Our company’s commitment to sustainable access to high-quality medicines is fundamental to our mission of empowering people worldwide to live healthier at every stage of life. We believe strongly in doing our part to build a better future by helping tackle some of the world’s complex health problems. To address the overall burden of disease, we go beyond making and distributing medicine to also building public awareness, supporting research and access to education, and pursuing innovative solutions for a holistic approach to prevention and treatment.

To help ensure access and strengthen the resilience of healthcare systems, we have set initial companywide goals around access to HIV treatment for adults and children and patient impact via healthcare professional training:

• Provide antiretroviral (ARV) therapy equivalent to a total of 30 million patients, including more than 2 million children living with HIV/AIDS, between 2022 and the end of 2025.
• Impact 100 million patients via healthcare professional (HCP) education and outreach regarding prevention, diagnosis and treatment options for cardiovascular disease, diabetes, cancer and other important chronic conditions to improve outcomes through the NCD Academy by the end of 2025.

Sustainable Access and Global Health

In 2021, the COVID-19 pandemic continued to have huge direct and indirect implications for patients and healthcare systems around the world. Pre-existing inequities were amplified, vulnerabilities revealed, and the urgency of building more resilient healthcare systems has become even more profound. Patients in lower-income countries and settings have been hit especially hard.

Ensuring sustainable access to medicine and empowering people to live healthier requires a multipronged approach that includes a global, diversified and reliable supply of medicine delivered via a broad and differentiated portfolio across geographies, policy solutions that remove barriers to medicine and care, greater regulatory harmony, disease awareness among patients and healthcare providers, and strong partnerships that address local patient needs while strengthening global public health.

An important part of driving access to high-quality, more affordable medicines for patients is breaking complex regulatory, policy and economic barriers while ensuring quality and patient safety. That entails working to support harmonization of different frameworks and economic models that preserve and advance access to high-quality medicines; building healthier markets that can sustain access in years to come; and strengthening an interconnected, global and resilient supply chain where domestic production does not impede the ability of health systems to respond to the ongoing needs of patients.

Learn more